UNSPSC 51373307: Acetaminophen/butalbital/codeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373307 Acetaminophen/butalbital/codeine is a Commodity code that represents pharmaceutical products, though recent state and local procurement activity under this code shows minimal direct alignment with the specific combination drug named in the code itself. The three recent opportunities posted under this code reflect broader pharmaceutical procurement activity: naloxone and drug deactivation systems, therapeutic pharmacy initiatives exploring direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals with OTC products distributed through cooperative purchasing networks. State and local governments soliciting under this code include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances administering pharmaceutical supply contracts on behalf of participating state and local facilities (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota and Oregon participants).

Recent activity spans Florida, Texas, and the Upper Midwest through Minnesota's cooperative. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries and a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capability information on direct-to-manufacturer prescription programs before issuing a formal RFP. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, and performance beginning July 1, 2026, requiring vendors to work through three authorized wholesalers and maintain cGMP and DSCSA compliance. The code's recent activity reflects state and local focus on prescription fulfillment efficiency, emergency response pharmaceuticals, and cooperative purchasing scale rather than procurement activity specifically targeting the acetaminophen/butalbital/codeine combination.